Clinical Trials Directory

Trials / Unknown

UnknownNCT00111371

Dopaminergic Enhancement of Learning and Memory in Healthy Adults and Patients With Dyslexia

Dopaminergic Enhancement of Learning and Memory (LL_001, Project on Dyslexia)

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
University Hospital Muenster · Academic / Other
Sex
Male
Age
18 Years – 35 Years
Healthy volunteers
Accepted

Summary

This study aims to determine whether levodopa, in combination with a high frequency training of (grammatical) rules, is effective in boosting learning success in healthy subjects and whether this kind of training in combination with levodopa improves reading and spelling abilities of patients with dyslexia.

Detailed description

Prior work by our group shows that d-amphetamine and the dopamine precursor levodopa markedly improve word learning success in healthy subjects. In this randomized, placebo-controlled, double-blind trial, we probe whether daily administration of levodopa, coupled with a training of grammatical rules, improves the training success in healthy adults as compared to placebo administration. In the second step of this study, patients with dyslexia will be trained with the identical protocol. We postulate that the combination of intensive training in language rules and levodopa improves the reading, writing, and spelling abilities of patients with dyslexia.

Conditions

Interventions

TypeNameDescription
DRUGLevodopa

Timeline

Start date
2005-01-01
Completion
2015-10-01
First posted
2005-05-20
Last updated
2014-12-05

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT00111371. Inclusion in this directory is not an endorsement.